Back
72· Active
Health & Science2d 10h ago
The FDA has granted expanded approval for the Arexvy respiratory syncytial virus (RSV) vaccine to include adults aged 18 to 59 who are at increased risk for the disease.
Silver Spring, Maryland, USA
Who
U.S. Food and Drug Administration (FDA) / GSK
What
The FDA has granted expanded approval for the Arexvy respiratory syncytial virus (RSV) vaccine to include adults aged 18 to 59 who are at increased risk for the disease.
When
Sat, 06 Jun 2026 23:20:05 GMT · 2d 10h ago
Where
Silver Spring, Maryland, USA · 39.0349°N, 76.9922°W
Why
Clinical data demonstrated strong immune response in younger adults with underlying medical conditions, addressing a previously unmet protective need.
The Frontline Impact
How this affects you
Millions of younger adults with chronic conditions like asthma or diabetes now have access to preventative immunization before the next peak virus season.
Story chain
1 event in this threadNo related history yet — this is the origin event.
Verified Sources & Citations
Credibility ratings reflect the AI ingestion pipeline's assessment of source provenance.